|
Zimmer Biomet Holdings Inc (NYSE: ZBH) |
|
|
|
|
Select the Financial Report:
|
|
Select the Period:
|
|
Description of Zimmer Biomet Holdings Inc's Business Segments
Zimmer Biomet Holdings Inc. is a prominent player in musculoskeletal healthcare, primarily focusing on orthopedic devices and related surgical solutions. The companys comprehensive offerings are designed to meet the specialized needs of orthopedic surgeons and their patients, ultimately enhancing surgical outcomes and improving quality of life. Below is a detailed overview of the segments, products, and services offered by Zimmer Biomet:
1. Segments
a. Orthopedic Reconstruction
This segment encompasses products intended for joint reconstruction surgeries, with a significant focus on hip and knee replacements. Zimmer Biomet provides an extensive range of options tailored to different surgical methods and patient requirements:
- Hip Implants: A diverse portfolio of total hip arthroplasties (THA) that includes options like cemented, cementless, and hybrid systems. Materials used include cobalt chrome, titanium, and specialized polyethylenes designed for durability and compatibility.
- Knee Implants: This includes total knee arthroplasties (TKA) products, such as partial knee replacements and gender-specific implants that cater to the anatomical needs of female patients, ensuring a better fit and improved outcomes.
b. Surgical Technologies
Zimmer Biomets surgical technologies segment is dedicated to enhancing the effectiveness and precision of orthopedic procedures. Options in this segment include:
- Robotic-assisted Surgery: The ROSA Robotics platform is a notable example, providing surgeons with sophisticated tools for planning and conducting knee and spine surgeries with enhanced accuracy and potentially shorter recovery times.
- Navigation Systems: Advanced imaging and guidance systems provide real-time support, improving the precision of implant placements during surgeries.
c. Dental Implants and Solutions
Zimmer Biomet also addresses dental restoration needs, offering a range of solutions that include:
- Dental Implants: This product line features various implant systems that replace missing teeth, from standard solutions to highly specialized implants utilizing advanced materials.
- Regenerative Solutions: Products such as bone grafts and growth factors aid in tissue regeneration in dental applications, supporting better healing and recovery.
d. Spine
The spine segment offers innovative solutions tailored for spinal surgery, which includes:
- Spinal Implants and Devices: A comprehensive range of products aimed at procedures like spinal fusion and stabilization, providing both structural support and functional recovery.
- Minimally Invasive Surgery Products: Technologies designed to minimize tissue disruption during surgery, which can lead to quicker patient recovery times and reduced postoperative complications.
e. Craniomaxillofacial & Thoracic (CMF)
Zimmer Biomet's offerings in this segment address the complexities of craniofacial and thoracic surgeries. Key products include:
- CMF Reconstruction Systems: Systems of plates, screws, and mesh utilized in reconstructive surgeries for the face and skull.
- Surgical Guides: Custom-designed devices that assist in precision preoperative planning and in executing surgeries accurately, enhancing overall surgical outcomes.
f. Biologics
The biologics segment focuses on products that utilize biological materials for healing and tissue regeneration, including:
- Growth Factors: Proteins specifically engineered to stimulate cellular growth and healing processes in various surgical scenarios.
- Bone Void Fillers: Specialized materials designed to support and enhance bone regeneration, often used in procedures needing grafting.
g. Trauma
This segment is centered around solutions for managing complex fractures and injuries. Key products include:
- Internal Fixation Devices: Plates, screws, and rods engineered for stabilizing fractured bones, assisting in proper alignment and healing.
- External Fixation Devices: Systems that stabilize and support fractures externally, often used in cases where internal fixation is impractical.
Products
Zimmer Biomets product portfolio is extensive, addressing a wide array of medical conditions and surgical techniques. Important categories within this portfolio include:
- Instruments: A range of surgical instruments designed for efficiency and ergonomics during both orthopedic and dental procedures.
- Implants: A broad selection of implants appropriate for both primary and revision surgeries, including options for shoulder, ankle, and elbow replacements.
- Patient-specific Solutions: Custom implants and surgical tools tailored to the unique anatomy of individual patients, ensuring better compatibility and outcomes.
Services
In addition to products, Zimmer Biomet provides a suite of services designed to add value to its offerings:
- Clinical Education and Training: Comprehensive educational programs for healthcare professionals aimed at ensuring the proficient use of products and adherence to surgical best practices.
- Surgical Planning Services: Tools and software that assist surgeons in preoperative planning, including advanced imaging solutions and analytical tools optimized for implant placement.
- Innovative Partnerships: Collaborations with healthcare providers and research institutions to enhance patient care and improve surgical outcomes through shared knowledge and resources.
Conclusion
Zimmer Biomet Holdings Inc. operates across a wide spectrum of the healthcare industry, delivering a vast array of orthopedic and surgical solutions that cater to the needs of both healthcare professionals and patients. The company's commitment to innovation is underscored by its expansive product offerings, advanced surgical technologies, and robust educational services. By continually striving for excellence, Zimmer Biomet aims to significantly enhance the effectiveness of healthcare providers in delivering successful patient outcomes.
Composition of Zimmer Biomet Holdings Inc Revenues by
Segments |
| |
| US |
|
 58.33 % |
of total Revenue |
| International |
|
41.67 % |
of total Revenue |
| Knees |
|
41.53 % |
of total Revenue |
| Hips |
|
25.97 % |
of total Revenue |
| S E T |
|
24.65 % |
of total Revenue |
| Technology Data Bone Cement and Surgical |
|
7.85 % |
of total Revenue |
| Net Sales And Profit Information zbh NetSalesAndOperatingProfitInformationLineItems |
|
100 % |
of total Revenue |
| Americas |
|
63.08 % |
of total Revenue |
| EMEA |
|
23.21 % |
of total Revenue |
| Asia Pacific |
|
13.71 % |
of total Revenue |
Q1 three months ended (Mar 31 2025)
|
| Revenues by Business Segments |
Revenues
(in millions $) |
%
(of total Revenues) |
| US |
1,113.60 |
58.33 % |
| International |
795.50 |
41.67 % |
| Knees |
792.90 |
41.53 % |
| Hips |
495.80 |
25.97 % |
| S E T |
470.50 |
24.65 % |
| Technology Data Bone Cement and Surgical |
149.90 |
7.85 % |
| Net Sales And Profit Information zbh NetSalesAndOperatingProfitInformationLineItems |
1,909.10 |
100 % |
| Americas |
1,204.30 |
63.08 % |
| EMEA |
443.10 |
23.21 % |
| Asia Pacific |
261.70 |
13.71 % |
| Total |
1,909.10 |
100 % |
Q1 three months ended (Mar 31 2025)
|
| Revenue Growth rates by Segment |
Y/Y Revenue
% |
Q/Q Revenue
% |
| US |
1.31 % |
- |
| International |
0.7 % |
- |
| Knees |
0.61 % |
- |
| Hips |
0.94 % |
- |
| S E T |
3.95 % |
- |
| Technology Data Bone Cement and Surgical |
-4.7 % |
- |
| Net Sales And Profit Information zbh NetSalesAndOperatingProfitInformationLineItems |
1.05 % |
- |
| Americas |
1.5 % |
- |
| EMEA |
-0.38 % |
- |
| Asia Pacific |
1.43 % |
- |
| Total |
1.05 % |
- |
Q1 three months ended (Mar 31 2025)
|
| Income by Business Segments |
Income
(in millions $) |
%
(Profit Margin) |
| Total |
182.60 |
9.56 % |
Q1 three months ended (Mar 31 2025)
|
| Income Growth rates by Segment |
Y/Y Income
% |
Q/Q Income
% |
| Total |
5.67 % |
- |
Annual Report on Zimmer Biomet Holdings Inc Divisions, Sales by Country |
| |
| US |
|
57.81 % |
of total Revenue |
| International |
|
42.19 % |
of total Revenue |
| Knees |
|
41.33 % |
of total Revenue |
| Hips |
|
26.03 % |
of total Revenue |
| S E T |
|
24.3 % |
of total Revenue |
| Technology Data Bone Cement and Surgical |
|
8.34 % |
of total Revenue |
| Net Sales And Profit Information zbh NetSalesAndOperatingProfitInformationLineItems |
|
100 % |
of total Revenue |
| Americas |
|
62.44 % |
of total Revenue |
| EMEA |
|
22.02 % |
of total Revenue |
| Asia Pacific |
|
15.53 % |
of total Revenue |
Twelve months ended 2024
|
| ZBH s Annual Revenue by Geography and Business Segments |
Sales
(in millions $) |
%
(of total Sales) |
| US |
4,439.00 |
57.81 % |
| International |
3,239.60 |
42.19 % |
| Knees |
3,173.50 |
41.33 % |
| Hips |
1,999.10 |
26.03 % |
| S E T |
1,865.70 |
24.3 % |
| Technology Data Bone Cement and Surgical |
640.30 |
8.34 % |
| Net Sales And Profit Information zbh NetSalesAndOperatingProfitInformationLineItems |
7,678.60 |
100 % |
| Americas |
4,794.80 |
62.44 % |
| EMEA |
1,691.10 |
22.02 % |
| Asia Pacific |
1,192.80 |
15.53 % |
| Total |
7,678.60 |
100 % |
Twelve months ended 2024
|
| ZBH s Annual Income by Country and Business Segments |
Income
(in millions $) |
%
(Profit Margin) |
| Total |
905.30 |
11.79 % |
Twelve months ended 2024
|
| Annual Revenue and Income Growth by Country and Business Segments |
% Y/Y Sales Growth |
% Y/Y Income Growth |
| US |
3.5 % |
- |
| International |
4.32 % |
- |
| Knees |
4.45 % |
- |
| Hips |
1.62 % |
- |
| S E T |
6.45 % |
- |
| Technology Data Bone Cement and Surgical |
0.68 % |
- |
| Net Sales And Profit Information zbh NetSalesAndOperatingProfitInformationLineItems |
3.85 % |
- |
| Americas |
3.69 % |
- |
| EMEA |
6.2 % |
- |
| Asia Pacific |
1.28 % |
- |
| Total |
3.85 % |
-11.69 % |
| Other |
- |
- |
|
|
